FDA Approves HIFU Clinical Trial for Recurrent Prost...(er. The Sonablate(R) 500 was develope...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
Date:5/13/2008
er.
The Sonablate(R) 500 was developed by Focus Surgery, Inc. and is manufactured by Misonix, Inc. (Nasdaq: MSON) who also holds distribution rights in Europe. Takai Hospital Supply Ltd. and THS International distribute the Sonablate(R) 500 in Southeast Asia and the Middle East.
'/>"/>
| SOURCE USHIFU, LLC Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
4. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
7. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
8. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
9. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
10. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
11. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
Post Your Comments:
(Date:11/27/2009)...Nov. 27 Booth - 3646/Sou...VAR ), a premier supplier of X-ray tubes and flat ...ll range of detectors at the RSNA Annual Meeting i...9. Varian will also be exhibiting X-ray tube tech...zed cancer treatment technologies. ,, Varian,s...
(Date:11/25/2009)...f., Nov. 25 Praxis Electronic Medi...merican Academy of Family Physicians, (AAFP) Famil...tion Survey for improving medical quality, health ...for new ARRA Stimulus legislation. Praxis also ran...sitive effect in determining their salary. Finally...
(Date:11/25/2009)...ov. 25 Pharmasset, Inc. ...company committed to discovering, developing and c...ns, reported financial results for the fiscal year...harmasset held $58.4 million in cash, cash equival...Update and 2009 Highlights ,, RG7128 ,, ...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Radiation Rescue 3A 4 Steps to Safeguard Your Family from the Other Inconvenient Truth The Health Hazards of Wireless Technology 49460 1Radiation Rescue 3A 4 Steps to Safeguard Your Family from the Other Inconvenient Truth The Health Hazards of Wireless Technology 49460 2Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference 12706 1NeuroTherm Completes Acquisition of the Micron Epidural Catheter 49458 1NeuroTherm Completes Acquisition of the Micron Epidural Catheter 49458 2[0] Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago[0] Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey[0] Pharmasset Reports Fiscal Year End 2009 Financial Results
...n., Sept. 22 VION,PHARMACEUTICALS, INC. (OTC Bull...red into an agreement with the Institut Paoli-Calm...er Phase I/II clinical trial of,laromustine (Clore...py in,patients aged 18-60 with previously untreate...nosis based on their cytogenetic profile., The In...
...for Efficacy in Drug Resistant Skin Infections, S...,announced the initiation of Phase 2 testing of th... antibacterial drug TR-701. The multicenter,trial ... once-daily doses,of 200, 300 and 400 milligrams o...fections (cSSSI) for five to seven days of treatme...
Other Medicine Technology:Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients 2Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients 3Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients 4Trius Doses First Patient in Antibacterial Phase 2 Trial 2(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued its ...mic data. It shows that the lethality of the viru...ng the virus,s current outbreak in the spring of 2...0 (s.d. 0.1). The H1N1 infectivity count, however,...ton (PRWEB) November 27, 2009 -- Biotech firm Repl...
(Date:11/27/2009)...AMIR, Israel, Nov. 27 Sh...mir" ), a leading provider of innovative products ...unced today that its board of directors had declar...of US$ 10 million (approximately NIS 37.62 million...e of exchange), or approximately US$ 0.609 (approx...
(Date:11/27/2009)... Voyant Health™ announced today that Spe... its TraumaCad Enterprise orthopedic templating so... , (PRWEB) November 27, 2...pectrum Health (Grand Rapids, Michigan) has licens...solution and its TraumaCad Extend workflow solutio...
(Date:11/26/2009)...ON, N.J., Nov. 27 The diabetes pop...er the next 25 years and annual medical spending o... from $113 billion today, according to a study pub...The National Changing Diabetes ® Program (NC...nalysis by a team from the University of Chicago. ...
(Date:11/26/2009)... No more letters from the North Pole, Textsant...essages from Santa , Nort...rational efficiencies at the North Pole Santa Clau...en all over the globe informed of his Christmas pr...;s research department have identified a large and...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2[0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased[0] Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[1] Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows[1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes
...t yesterday with the office of Minister for Ageing...Ps attending aged care facilities, //as set out in...
The current structure of the Medicare Benefits ..., said today the number of general practitioners a...
...ada has warned women strongly about the side effec...'. Evra can trigger off //the development of sever...ches which contains ethinyl estradiol is available...g blood clots. Use of oral birth control pills co...
...s in the Department of Obstetrics, Gynecology & Re... The Albert Einstein //College of Medicine report ...ced reduced genital sensation and were more likely.... With the help of non-invasive techniques, they s...
..., Flu killed about 12,000 people last winter and t... to a shortage in vaccines.//
This year due ...ccine millions of elderly and vulnerable patients ...ar. Researchers warn that those who do not get vac...
... gamble at least five times a year have more healt... a new study reveals.//
And people with a se...ort serious health problems, such as increased hea...red is whether gambling is associated with health ...
...ch published in the November edition of the journa... 7 to 11 in Augusta, Georgia. A quarter of the kid...oblems, reported the online edition of the health ..., basketball, soccer or jump rope - every day for ...
Other Medicine News:Health News:Competitive women cyclists experience reduced genital sensation 2Health News:Flu Vaccine Shortage In Britain Causes Anxiety 2Health News:Odds Are That Gamblers Have More Health Problems 2A Better Health Deal for Aged Care ResidentsContraceptive tailed by Controversies:Birth Control PatchCompetitive women cyclists experience reduced genital sensationFlu Vaccine Shortage In Britain Causes Anxiety Odds Are That Gamblers Have More Health ProblemsExercise may cut snoring in overweight kids
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |